BeiGene, Ltd.
06160
2024 3 31
13.09
571 XIVA
2024 3 31
2024 3 31
2024
2024 5 8
1
1995 (Private Securities Litigation
Reform Act of 1995)
10-Q
2024 5 8
Olivier Brandicourt Margaret Han Dugan
Donald W. Glazer Michael Goller Anthony C. Hooper
Ranjeev Krishana Alessandro Riva Corazon (Corsee) D. Sanders
2
2024
7.52 7.47 82%
4.89
153% 243% FDA
BTK
sonrotoclax
BTK CDAC
ADC
BGNE
06160 688235
2024
15
(John V. Oyler)
BTK
3
3 31
2024 2023 (%)
$ 746,918 $ 410,291 82%
$ 4,734 $ 37,510 (87)%
$ 751,652 $ 447,801 68%
GAAP $ (261,348) $ (371,258) (30)%
* $ (147,341) $ (275,859) (47)%
* GAAP (GAAP)
GAAP GAAP
2024
3.51 153%
(TN) (CLL)
(R/R)CLL
BTK 2024
6,700
243%
CLL (WM)
3 ALPINE 3 ASCEND
R/R CLL
(CR)
(FDA) CD20
R/R
4
2024
1.45 26%
(NSCLC)
FDA (ESCC)
(BLA) FDA
ESCC
FDA (PDUFA) FDA
2024 7
Sonrotoclax BCL-2
FDA R/R (MCL)
R/R MCL WM
TN CLL 3 850
BGB-16673(BTK CDAC)
R/R MCL R/R CLL
220
2024 R/R CLL 3
5
TIGIT PD-L1 NSCLC 3
BGB-A445 OX40 LBL-007 LAG-3
BGB-15025 HPK1 2024
KRAS MTA PRMT5 EGFR CDAC 2024
BGB-43395 CDK4
4
BG-68501 CDK2 :
BG-C9074 (B7H4 ADC) 1
2024 LBL-007 LAG-3 BGB-A445 OX40
(NMPA)
CEA-ADC FGFR2b-ADC 2024
6
(USPTO) Pharmacyclics
USPTO 12
2023
7
2024
2024 3 31 7.52 2023
4.48
153%
243%
2024 3 31 7.47 2023
4.10 82%
2024 3 31
3.51 1.39
2024 83%
80%
7
GAAP GAAP
2024 2023 2024 2023
(%) (%)
$ 460,638 $ 408,584 13% $ 405,440 $ 361,696 12%
$ 427,427 $ 328,499 30% $ 372,146 $ 283,154 31%
$ – $ 187 (100)% $ – $ –
$ 888,065 $ 737,270 20% $ 777,586 $ 644,850 21%
2024 GAAP
2024
3,500
(SG&A) 2024 GAAP SG&A
2024 SG&A 57% 80%
2024 GAAP 30%
47%
GAAP 2024 3 31 GAAP
2024 3 31 0.19
(ADS) 2.41 0.26
ADS 3.34
2024 3 31
3.09 5.64
2024
2024 10-Q
8
10,000
www.beigene.com.cn
1995 (Private Securities Litigation
Reform Act of 1995)
10-Q
(+86 10) 5895-8058 (+86 21) 3159-1070
ir@beigene.com media@beigene.com
9
ADS ADS
3 31
2024 2023
$ 746,918 $ 410,291
4,734 37,510
751,652 447,801
124,935 81,789
626,717 366,012
460,638 408,584
427,427 328,499
– 187
888,065 737,270
(261,348) (371,258)
16,160 16,016
1,762 18,303
(243,426) (336,939)
7,724 11,492
(251,150) (348,431)
$ (0.19) $ (0.26)
1,355,547,626 1,354,164,760
ADS $ (2.41) $ (3.34)
ADS 104,272,894 104,166,520
10
GAAP
2024 2023
3 31 12 31
$ 2,807,436 $ 3,188,584
435,294 358,027
447,345 416,122
1,417,992 1,324,154
5,667,681 5,805,275
356,575 315,111
569,438 693,731
225,530 238,666
1,025,992 885,984
2,307,320 2,267,948
$ 3,360,361 $ 3,537,327
(GAAP)
GAAP
GAAP GAAP
GAAP GAAP
GAAP GAAP
GAAP
GAAP GAAP
GAAP
GAAP
GAAP
GAAP GAAP
GAAP GAAP
11
GAAP GAAP
3 31
2024 2023
GAAP
GAAP $ 124,935 $ 81,789
2,345 2,180
1,183 799
$ 121,407 $ 78,810
GAAP
GAAP $ 460,638 $ 408,584
38,045 34,028
17,153 12,860
$ 405,440 $ 361,696
GAAP
GAAP $ 427,427 $ 328,499
50,669 41,360
4,612 3,985
$ 372,146 $ 283,154
GAAP
GAAP $ 888,065 $ 737,270
88,714 75,388
21,765 16,845
– 187
$ 777,586 $ 644,850
GAAP
GAAP $ (261,348) $ (371,258)
88,714 75,388
24,110 19,025
1,183 986
$ (147,341) $ (275,859)
12